Error: Could not add to watchlist. X

CF Equities HAIG - Pharma

+ Watchlist
CFEQPHB:LX
68.12
EUR
0.04
0.06%
As of 00:59:30 ET on 02/08/2016.
Fund Type
FCP
52Wk Range
67.49 - 93.04
1 Yr Return
-12.89%
YTD Return
-5.59%
Previous Close
68.08
52Wk Range
67.49 - 93.04
1 Yr Return
-12.32%
YTD Return
-5.59%
Fund Type
FCP
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 02/08/2016)
68.12
Total Assets (m EUR) (on 02/08/2016)
3.607
Inception Date
08/18/1999
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
2.00%
Expense Ratio
3.06%
Top Fund Holdings
Name Position Value % of Fund
Burcon NutraScience Corp 221.26 k 316.54 k 8.09
4SC AG 71.19 k 283.06 k 7.24
M4E AG 91.62 k 281.99 k 7.21
Biofrontera AG 145.00 k 271.15 k 6.93
SYMTEX 8 12/03/18 322.00 252.77 k 6.46
Formycon AG 9.00 k 212.58 k 5.43
MorphoSys AG 3.00 k 175.14 k 4.48
US Dollar Spot 161.17 147.81 k 3.78
GlaxoSmithKline PLC 7.50 k 141.59 k 3.62
Bachem Holding AG 3.00 k 141.31 k 3.61
Profile
CF Equities HAIG - Pharma is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to achieve the highest possible growth with its invested capital. The Fund invests primarily in equities of companies within the health industry. Pharmaceuticals, Health Services, Biotech, and the production of drugs are all possible sectors to be invested in worldwide.
ADDRESS
Hauck & Aufhaeuser Inves Gesell SA
21, Avenue de la Liberte
L-1931 Luxembourg
Luxembourg
PHONE
Tel +352 45 13 14 500